Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Long-term persistence in patients with osteoporosis receiving denosumab in routine practice: 36-month non-interventional, observational study.

Borek DM, Smith RC, Gruber CN, Gruber BL.

Osteoporos Int. 2019 Jul;30(7):1455-1464. doi: 10.1007/s00198-019-04963-2. Epub 2019 Apr 22.

PMID:
31011760
2.

Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study.

Beall DP, Feldman RG, Gordon ML, Gruber BL, Lane JM, Valenzuela G, Yim D, Alam J, Krege JH, Krohn K.

Osteoporos Int. 2016 Mar;27(3):1191-1198. doi: 10.1007/s00198-015-3353-1. Epub 2015 Nov 10.

PMID:
26556737
3.

A case of rheumatoid arthritis with Felty syndrome complicated by late-onset ankylosing spondylitis and psoriatic arthritis: a potpourri of rheumatic diseases.

Godhwani S, Gruber BL, Finzel K.

J Clin Rheumatol. 2015 Jan;21(1):53-5. doi: 10.1097/RHU.0000000000000205. No abstract available.

PMID:
25539441
4.

A case of methimazole-induced chronic arthritis masquerading as seronegative rheumatoid arthritis.

Gruber CN, Finzel K, Gruber BL.

J Clin Rheumatol. 2014 Jun;20(4):229-32. doi: 10.1097/RHU.0000000000000104.

PMID:
24847752
5.

Novel ANKH amino terminus mutation (Pro5Ser) associated with early-onset calcium pyrophosphate disease with associated phosphaturia.

Gruber BL, Couto AR, Armas JB, Brown MA, Finzel K, Terkeltaub RA.

J Clin Rheumatol. 2012 Jun;18(4):192-5. doi: 10.1097/RHU.0b013e3182582c3d.

6.

Osseous sarcoidosis treated with tumor necrosis factor-inhibitors: case report and review of the literature.

Hasni SA, Kunz D, Finzel K, Gruber BL.

Spine (Phila Pa 1976). 2010 Aug 15;35(18):E904-7. Review.

PMID:
21381234
7.

Sarcoidosis in World Trade Center rescue workers presenting with rheumatologic manifestations.

Bowers B, Hasni S, Gruber BL.

J Clin Rheumatol. 2010 Jan;16(1):26-7. doi: 10.1097/RHU.0b013e3181c78856.

PMID:
20051752
8.

Successful treatment of sternal fracture nonunion with teriparatide.

Chintamaneni S, Finzel K, Gruber BL.

Osteoporos Int. 2010 Jun;21(6):1059-63. doi: 10.1007/s00198-009-1061-4. Epub 2009 Oct 27.

PMID:
19859645
9.

Prophylactic antibiotic usage for Pneumocystis jirovecii pneumonia in patients with systemic lupus erythematosus on cyclophosphamide: a survey of US rheumatologists and the review of literature.

Gupta D, Zachariah A, Roppelt H, Patel AM, Gruber BL.

J Clin Rheumatol. 2008 Oct;14(5):267-72. doi: 10.1097/RHU.0b013e31817a7e30. Review.

PMID:
18679133
10.

Chemotaxis of human monocyte-derived dendritic cells to complement component C1q is mediated by the receptors gC1qR and cC1qR.

Vegh Z, Kew RR, Gruber BL, Ghebrehiwet B.

Mol Immunol. 2006 Mar;43(9):1402-7. Epub 2005 Sep 2.

PMID:
16140380
11.

Protease-activated receptor-2 (PAR-2) expression in human fibroblasts is regulated by growth factors and extracellular matrix.

Gruber BL, Marchese MJ, Santiago-Schwarz F, Martin CA, Zhang J, Kew RR.

J Invest Dermatol. 2004 Nov;123(5):832-9.

12.

Mast cells in the pathogenesis of fibrosis.

Gruber BL.

Curr Rheumatol Rep. 2003 Apr;5(2):147-53. Review.

PMID:
12628046
13.

Statins and osteoporosis: can these lipid-lowering drugs also bolster bones?

Cruz AC, Gruber BL.

Cleve Clin J Med. 2002 Apr;69(4):277-8, 280-2, 287-8. Review.

PMID:
11996199
14.

The differentiation and function of myofibroblasts is regulated by mast cell mediators.

Gailit J, Marchese MJ, Kew RR, Gruber BL.

J Invest Dermatol. 2001 Nov;117(5):1113-9.

15.

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial.

Adachi JD, Saag KG, Delmas PD, Liberman UA, Emkey RD, Seeman E, Lane NE, Kaufman JM, Poubelle PE, Hawkins F, Correa-Rotter R, Menkes CJ, Rodriguez-Portales JA, Schnitzer TJ, Block JA, Wing J, McIlwain HH, Westhovens R, Brown J, Melo-Gomes JA, Gruber BL, Yanover MJ, Leite MO, Siminoski KG, Nevitt MC, Sharp JT, Malice MP, Dumortier T, Czachur M, Carofano W, Daifotis A.

Arthritis Rheum. 2001 Jan;44(1):202-11.

16.
17.
18.

Thermal and EMG biofeedback learning in nonhuman primates.

Gruber BL, Taub E.

Appl Psychophysiol Biofeedback. 1998 Mar;23(1):1-12.

PMID:
9653509
19.

Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor.

Blair RJ, Meng H, Marchese MJ, Ren S, Schwartz LB, Tonnesen MG, Gruber BL.

J Clin Invest. 1997 Jun 1;99(11):2691-700.

20.

Isolated pulmonary microangiitis mimicking pneumonia in a patient infected with human immunodeficiency virus.

Gruber BL, Schranz JA, Fuhrer J, Kane PB.

J Rheumatol. 1997 Apr;24(4):759-62.

PMID:
9101514
21.

Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis.

Gruber BL, Kew RR, Jelaska A, Marchese MJ, Garlick J, Ren S, Schwartz LB, Korn JH.

J Immunol. 1997 Mar 1;158(5):2310-7.

PMID:
9036979
22.

Growth factors in subglottic stenosis.

Scioscia KA, Miller F, April MM, Gruber BL.

Ann Otol Rhinol Laryngol. 1996 Dec;105(12):936-43.

PMID:
8973279
23.

Elevated levels of 92-kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis.

Sorbi D, French DL, Nuovo GJ, Kew RR, Arbeit LA, Gruber BL.

Arthritis Rheum. 1996 Oct;39(10):1747-53.

PMID:
8843867
24.

Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker.

Gruber BL, Sorbi D, French DL, Marchese MJ, Nuovo GJ, Kew RR, Arbeit LA.

Clin Immunol Immunopathol. 1996 Feb;78(2):161-71.

PMID:
8625558
25.

Mast cells induce T-cell adhesion to human fibroblasts by regulating intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression.

Meng H, Marchese MJ, Garlick JA, Jelaska A, Korn JH, Gailit J, Clark RA, Gruber BL.

J Invest Dermatol. 1995 Dec;105(6):789-96.

26.

Mast cells are potent regulators of endothelial cell adhesion molecule ICAM-1 and VCAM-1 expression.

Meng H, Tonnesen MG, Marchese MJ, Clark RA, Bahou WF, Gruber BL.

J Cell Physiol. 1995 Oct;165(1):40-53.

PMID:
7559805
27.

Angiogenic factors stimulate mast-cell migration.

Gruber BL, Marchese MJ, Kew R.

Blood. 1995 Oct 1;86(7):2488-93.

PMID:
7545457
28.

Murine mast cells express two types of C1q receptors that are involved in the induction of chemotaxis and chemokinesis.

Ghebrehiwet B, Kew RR, Gruber BL, Marchese MJ, Peerschke EI, Reid KB.

J Immunol. 1995 Sep 1;155(5):2614-9.

PMID:
7650391
29.

Mast cells: accessory cells which potentiate fibrosis.

Gruber BL.

Int Rev Immunol. 1995;12(2-4):259-79. Review. No abstract available.

PMID:
7544388
30.

Mast cells in scleroderma.

Gruber BL.

Clin Dermatol. 1994 Jul-Sep;12(3):397-406. Review. No abstract available.

PMID:
7954197
31.

Transforming growth factor-beta 1 mediates mast cell chemotaxis.

Gruber BL, Marchese MJ, Kew RR.

J Immunol. 1994 Jun 15;152(12):5860-7.

PMID:
7515916
32.

Anti-laminin autoantibodies in collagen vascular diseases: the use of adequate controls in studies of autoimmune responses to laminin.

Cohen DE, Kaufman LD, Varma AA, Seibold JR, Stiller M, Gruber BL.

Ann Rheum Dis. 1994 Mar;53(3):191-3.

33.

Effects of commonly prescribed nonsteroidal anti-inflammatory drugs on thyroid hormone measurements.

Bishnoi A, Carlson HE, Gruber BL, Kaufman LD, Bock JL, Lidonnici K.

Am J Med. 1994 Mar;96(3):235-8.

PMID:
8154511
34.

Fibrogenic growth factors in the eosinophilia-myalgia syndrome and the toxic oil syndrome.

Kaufman LD, Gruber BL, Gomez-Reino JJ, Miller F.

Arch Dermatol. 1994 Jan;130(1):41-7.

PMID:
8285738
35.

Immunological responses of breast cancer patients to behavioral interventions.

Gruber BL, Hersh SP, Hall NR, Waletzky LR, Kunz JF, Carpenter JK, Kverno KS, Weiss SM.

Biofeedback Self Regul. 1993 Mar;18(1):1-22.

PMID:
8448236
36.

Mast cell changes in scleroderma. Presence of MCT cells in the skin and evidence of mast cell activation.

Irani AM, Gruber BL, Kaufman LD, Kahaleh MB, Schwartz LB.

Arthritis Rheum. 1992 Aug;35(8):933-9.

PMID:
1642658
37.

Simultaneous onset of systemic sclerosis (scleroderma) and lung cancer: a case report and histologic analysis of fibrogenic peptides.

Gruber BL, Miller F, Kaufman LD.

Am J Med. 1992 Jun;92(6):705-8. No abstract available.

PMID:
1605158
38.

Interleukin-4 levels in the eosinophilia-myalgia syndrome.

Kaufman LD, Gruber BL, Needleman BW.

Am J Med. 1991 Dec;91(6):664-5. No abstract available.

PMID:
1750440
39.

Clinical follow-up and immunogenetic studies of 32 patients with eosinophilia-myalgia syndrome.

Kaufman LD, Gruber BL, Gregersen PK.

Lancet. 1991 May 4;337(8749):1071-4.

PMID:
1673503
40.

Immunoglobulin E, mast cells, endogenous antigens, and arthritis.

Gruber BL.

Rheum Dis Clin North Am. 1991 May;17(2):333-42. Review.

PMID:
1862242
41.
42.

Cutaneous manifestations of the L-tryptophan-associated eosinophilia-myalgia syndrome: a spectrum of sclerodermatous skin disease.

Kaufman LD, Seidman RJ, Phillips ME, Gruber BL.

J Am Acad Dermatol. 1990 Dec;23(6 Pt 1):1063-9.

PMID:
2273104
43.

The mast cell as an effector of connective tissue degradation: a study of matrix susceptibility to human mast cells.

Gruber BL, Schwartz LB.

Biochem Biophys Res Commun. 1990 Sep 28;171(3):1272-8.

PMID:
2222442
44.
45.
46.

Eosinophilic neuritis, perimyositis, and vasculitis associated with ingestion of L-tryptophan.

Kaufman LD, Finn AF Jr, Seidman RJ, Pampati J, Peress NS, Miller F, Sokoloff L, Gruber BL.

J Rheumatol. 1990 Jun;17(6):795-800.

PMID:
2388201
47.

Electroconvulsive therapy and cyclophosphamide in combination for severe neuropsychiatric lupus with catatonia.

Fricchione GL, Kaufman LD, Gruber BL, Fink M.

Am J Med. 1990 Apr;88(4):442-3. No abstract available.

PMID:
2327432
48.

Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation.

Gruber BL, Marchese MJ, Suzuki K, Schwartz LB, Okada Y, Nagase H, Ramamurthy NS.

J Clin Invest. 1989 Nov;84(5):1657-62.

49.

Late cutaneous Lyme disease: acrodermatitis chronica atrophicans.

Kaufman LD, Gruber BL, Phillips ME, Benach JL.

Am J Med. 1989 Jun;86(6 Pt 2):828-30. No abstract available.

PMID:
2729343
50.

Anti-IgE autoantibodies in systemic sclerosis (scleroderma).

Kaufman LD, Gruber BL, Marchese MJ, Seibold JR.

Ann Rheum Dis. 1989 Mar;48(3):201-5.

Supplemental Content

Loading ...
Support Center